Global profiling of signaling networks: Study of breast cancer stem cells and potential regulation

Oncologist

Volumn 16, Issue 7, 2011, Pages 966-979

  Wang, Hongxia ^a   Huang, Mingzhu ^b   Zhang, David Y ^c   Zhang, Fengchun ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Breast cancer; Proteome profile; Signaling network; Stem cell

Indexed keywords

ALPHA TUBULIN; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD24 ANTIGEN; CHECKPOINT KINASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); FOCAL ADHESION KINASE; HERMES ANTIGEN; INITIATION FACTOR 4B; MAMMALIAN TARGET OF RAPAMYCIN; MESOTHELIN; PROTEIN BAD; PROTEIN BCL 6; PROTEIN CDC42; PROTEIN KINASE C; RETINOBLASTOMA PROTEIN; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; SUMO 1 PROTEIN; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CANCER TISSUE; CELL CYCLE G2 PHASE; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOCARCINOMA; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; NEOPLASTIC STEM CELLS; SIDE-POPULATION CELLS; SIGNAL TRANSDUCTION;

EID: 79960873300     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0230     Document Type: Article

References (21)

1. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev On col Hematol 2004;51:1-28.
2. Pierce GB, Johnson LD. Differentiation and cancer. In Vitro 1971;7:140 3
3. Potter VR. Phenotypic diversity in experimental hepatomas: The concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer 1978;38:1-23.
4. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-512.
5. Kim M, Turnquist H, Jackson J et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002;8:22-28.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-3988.
7. Sheridan C, Kishimoto H, Fuchs RK et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 2006;8:R59.
8. Patrawala L, Calhoun T, Schneider-Broussard R et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2 + and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005;65: 6207-6219.
9. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895-902.
10. Carlson MR, Zhang B, Fang Z et al. Gene connectivity, function, and sequence conservation: Predictions from modular yeast co-expression networks. BMC Genomics 2006;7:40.
11. Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. STEM CELLS 2002;20:11-20.
12. Olempska M, Eisenach PA, Ammerpohl O et al. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007;6:92-97.
13. Tanaka H, Nakamura M, Kameda C et al. The Hedgehog signaling pathway plays an essential role in maintaining the CD44 + CD24-/low subpopula-tion and the side population of breast cancer cells. Anticancer Res 2009;29: 2147-2157.
14. Botchkina IL, Rowehl RA, Rivadeneira DE et al. Phenotypic subpopula-tions of metastatic colon cancer stem cells: Genomic analysis. Cancer Genomics Proteomics 2009;6:19-29.
15. Korkola JE, Houldsworth J, Chadalavada RS et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006;66:820-827.
16. Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351: 2817-2826.
17. Van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
18. Kreike B, Halfwerk H, Kristel P et al. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Clin Cancer Res 2006;12:5705-5712.
19. Liu R, Wang X, Chen GY et-al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217-226.
20. Zhang DY, Ye F, Gao L et al. Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div 2009;4:20.
21. Ye F, Che Y, McMillen E et al. The effect of Scutellaria baicalensis on the signaling network in hepatocellular carcinoma cells. Nutr Cancer 2009; 61:530-537.